Studies & Sites
Clinical studies, protocols, sites and investigators
| Study | Protocol | Phase | Blinding | EudraCT / CTIS | IND | Status |
|---|---|---|---|---|---|---|
| Loading... | ||||||
SUSAR Queue
Suspected unexpected serious adverse reactions awaiting assessment and expedited reporting
| Case | Study | Status | Clock | Due | Days left | Flags |
|---|---|---|---|---|---|---|
| Loading... | ||||||
IB / RSI Library
Investigator's Brochures and Reference Safety Information versions
Unblinding Requests
Emergency and regulatory unblinding requests, with audit trail
Line Listings
SUSAR and serious adverse event line listings by study and period
Investigator Notifications
SUSAR notifications to investigators and ethics committees
Submissions (EVCTM / IND)
EudraVigilance clinical trials module and FDA IND safety report routing
Dashboard
Post-marketing case processing, signals and periodic reporting
My work
| Case | Status | Deadline | |
|---|---|---|---|
| Loading… | |||
Upcoming deadlines
Team & cover
| Person | Availability | Open / cap | Due today |
|---|
Clinical Safety
Clinical-trial safety: SUSARs, DSUR, unblinding and investigator notifications — ICH E2A | E2F | EU CTR 536/2014 | 21 CFR 312.32
No cases processed yet. Submit a report to get started.
Submit report
Paste or upload any incoming adverse event or quality complaint report for AI processing.
Cases
Post-marketing Individual Case Safety Reports
| Case | Status | Entered by | Deadline | Action | |||
|---|---|---|---|---|---|---|---|
Loading cases... | |||||||
Safety Product Master
Approvals per market, birth dates, reference safety information versions and exposure — the basis for periodic-report schedules, PADER/PSUR/DSUR case selection and expectedness.
| Product | Active Substance | Markets | IBD | DIBD | RSI Versions | |
|---|---|---|---|---|---|---|
Loading… | ||||||
Companies & Projects
Who the safety data belongs to. Each client company (MAH / sponsor) has its own products, cases, reports and regulatory identity — the E2B safety report ID, gateway sender ID and safety contact.
| Company | Code | Project / services | FDA gateway | Safety contact | Products | Cases | Status | |
|---|---|---|---|---|---|---|---|---|
Loading… | ||||||||
Master Case Database
Search and filter every case, then export exactly what you see as CSV. De-identified (age group only, no patient/reporter identifiers).
Loading… |
Signal Management
Step 1 of 2 — Disproportionality detection (PRR / ROR / BCPNN / EBGM). Detected signals are governed in
| Report ID | Generated | Cases Analyzed | Signals | Strong | Moderate | Actions |
|---|---|---|---|---|---|---|
Loading... | ||||||
PSUR / PBRER
Periodic benefit-risk evaluation reports compiled from the case history — ICH E2C(R2)
| Report ID | Product | Period | Generated | Total Cases | Serious | Expedited | Actions |
|---|---|---|---|---|---|---|---|
Loading... | |||||||
Literature Monitor
Search PubMed, Europe PMC, Semantic Scholar and WHO IRIS — or paste an article — to screen for individual case reports (ICH E2B)
Case Workflow
Review, approve, and track cases through to regulatory submission
| Case | Stage | Entered by | Assigned to | Deadline | Action | |
|---|---|---|---|---|---|---|
Loading... | ||||||
Case Form
Structured adverse event case entry — ICH E2B(R3) / MedDRA / 21 CFR compliant
Process Logs
Per-stage pipeline traces — every step logged with timing, tokens, inputs & outputs
Select a trace on the left to see the full step-by-step log for that processing run.
Settings / Debug
Model configuration and diagnostic tools
Privacy & Compliance
HIPAA · GDPR · 21 CFR Part 11 · ICH E2B data protection controls
Pseudonymises direct identifiers. Safety data retained per ICH E2B / HIPAA §164.530(j).
HIPAA §164.312(b) · GDPR Art. 30 · 21 CFR Part 11 §11.10(e)
One entry per case — purpose, lawful basis, recipients, retention period, cross-border transfer basis.
HIPAA §164.530(j) · GDPR Art. 5(1)(e) storage limitation · 21 CFR 312
User management
Access control and audit trail — 21 CFR Part 11 §11.10(d)(e) · EU Annex 11 §12.1
System users
QPPV oversight
GVP Module I — benefit-risk and compliance overview for the Qualified Person for Pharmacovigilance
Deadline calendar
Submission deadlines for open cases — 7 days for fatal or life-threatening, 15 days for other serious reports (ICH E2A)
| Case | Status | Entered by | Deadline | Action |
|---|---|---|---|---|
Loading… | ||||
Periodic reports
DSUR (ICH E2F) · RMP (EU GVP Module V) · PADER (21 CFR 314.80(c)(2))
Signal lifecycle
GVP Module IX — triage, assess, validate and action signals found by disproportionality analysis
Analytics & KPIs
Submission timeliness, case volume trends, signal heatmap and CAPA status
| Stage | No edits in stage | Mean hands-on | MedDRA terms changed |
|---|
Loading…
Signal Explainability — Feature Attribution
EMA EVDAS Signal Benchmark STUB
Batch / Bulk Case Import
Import multiple cases from ZIP (E2B XML), CSV, or FHIR R4 Bundle
One E2B(R3) XML file (a batch of one or more ICSRs) from an intake vendor, partner or other safety database. Fields are read as coded; no AI model is used and nothing leaves the system. Cases go to review. A report already imported is refused as a duplicate.
Click Refresh to load audit events.
Click Refresh to load SOPs.
Loading configuration...
No products registered. Click Add Product to register a medicinal product.
Intake Queue
Every report that reaches us — email, web portal, phone, text message, EHR, literature, social media and partner systems. Valid reports become cases automatically; the rest wait here until someone completes them.
| Reference | Received | Channel | Reporter | Subject | Status | Missing information | Acknowledged | Case |
|---|---|---|---|---|---|---|---|---|
Loading… | ||||||||
Intake Channels
Where reports come from for each company, how reporters are thanked, and whether valid reports become cases automatically.
Integrations
Click Test Connection to check LIMS status.
Click Test Connection to check IMAP status.
Click Test to check connectivity.
Click Test to check connectivity.
Click Test to check connectivity.
No watchlist entries. Add a drug to start automated surveillance.
Loading…
Data Migration
Migrate historical ICSR cases from your AWS S3 bucket, Azure Blob Storage, or any ICH E2B(R3) XML source into ZeniX AI Vigilance.
Click Check Connection to verify S3 connectivity and estimate file count.
Data Sources
MedDRA licensed terminology integration · Production MAH case data for model augmentation
Select multiple .asc files (llt.asc, pt.asc, hlt.asc, hlgt.asc, soc.asc, etc.) downloaded from the MSSO subscriber portal.
AI Assistant
I can answer evidence-based questions using case data, FAERS background rates, screened literature, and regulatory guidance (ICH E2A/E2B, GVP, FDA 21 CFR).
Every claim will cite its exact source field. Try a suggested question above, or type your own.